Copyright Reports & Markets. All rights reserved.

Global Cannabis-based Medicines Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Cannabis-based Medicines Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 CBD (Cannabidiol) Based
      • 1.4.3 THC (Tetrahydrocannabinol) Based
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Cannabis-based Medicines Market Share by Application (2014-2025)
      • 1.5.2 Oral Solution
      • 1.5.3 Tablets
      • 1.5.4 Patches
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Cannabis-based Medicines Market Size
    • 2.2 Cannabis-based Medicines Growth Trends by Regions
      • 2.2.1 Cannabis-based Medicines Market Size by Regions (2014-2025)
      • 2.2.2 Cannabis-based Medicines Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Cannabis-based Medicines Market Size by Manufacturers
      • 3.1.1 Global Cannabis-based Medicines Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Cannabis-based Medicines Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Cannabis-based Medicines Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cannabis-based Medicines Key Players Head office and Area Served
    • 3.3 Key Players Cannabis-based Medicines Product/Solution/Service
    • 3.4 Date of Enter into Cannabis-based Medicines Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Cannabis-based Medicines Market Size by Type (2014-2019)
    • 4.2 Global Cannabis-based Medicines Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Cannabis-based Medicines Market Size (2014-2019)
    • 5.2 Cannabis-based Medicines Key Players in United States
    • 5.3 United States Cannabis-based Medicines Market Size by Type
    • 5.4 United States Cannabis-based Medicines Market Size by Application

    6 Europe

    • 6.1 Europe Cannabis-based Medicines Market Size (2014-2019)
    • 6.2 Cannabis-based Medicines Key Players in Europe
    • 6.3 Europe Cannabis-based Medicines Market Size by Type
    • 6.4 Europe Cannabis-based Medicines Market Size by Application

    7 China

    • 7.1 China Cannabis-based Medicines Market Size (2014-2019)
    • 7.2 Cannabis-based Medicines Key Players in China
    • 7.3 China Cannabis-based Medicines Market Size by Type
    • 7.4 China Cannabis-based Medicines Market Size by Application

    8 Japan

    • 8.1 Japan Cannabis-based Medicines Market Size (2014-2019)
    • 8.2 Cannabis-based Medicines Key Players in Japan
    • 8.3 Japan Cannabis-based Medicines Market Size by Type
    • 8.4 Japan Cannabis-based Medicines Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Cannabis-based Medicines Market Size (2014-2019)
    • 9.2 Cannabis-based Medicines Key Players in Southeast Asia
    • 9.3 Southeast Asia Cannabis-based Medicines Market Size by Type
    • 9.4 Southeast Asia Cannabis-based Medicines Market Size by Application

    10 India

    • 10.1 India Cannabis-based Medicines Market Size (2014-2019)
    • 10.2 Cannabis-based Medicines Key Players in India
    • 10.3 India Cannabis-based Medicines Market Size by Type
    • 10.4 India Cannabis-based Medicines Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Cannabis-based Medicines Market Size (2014-2019)
    • 11.2 Cannabis-based Medicines Key Players in Central & South America
    • 11.3 Central & South America Cannabis-based Medicines Market Size by Type
    • 11.4 Central & South America Cannabis-based Medicines Market Size by Application

    12 International Players Profiles

    • 12.1 GW Pharmaceuticals plc
      • 12.1.1 GW Pharmaceuticals plc Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Cannabis-based Medicines Introduction
      • 12.1.4 GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2014-2019)
      • 12.1.5 GW Pharmaceuticals plc Recent Development
    • 12.2 INSYS Therapeutics
      • 12.2.1 INSYS Therapeutics Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Cannabis-based Medicines Introduction
      • 12.2.4 INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2014-2019)
      • 12.2.5 INSYS Therapeutics Recent Development
    • 12.3 Aequus Pharmaceuticals
      • 12.3.1 Aequus Pharmaceuticals Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Cannabis-based Medicines Introduction
      • 12.3.4 Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2014-2019)
      • 12.3.5 Aequus Pharmaceuticals Recent Development
    • 12.4 Axim Biotechnologies
      • 12.4.1 Axim Biotechnologies Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Cannabis-based Medicines Introduction
      • 12.4.4 Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2014-2019)
      • 12.4.5 Axim Biotechnologies Recent Development
    • 12.5 Revive Therapeutics
      • 12.5.1 Revive Therapeutics Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Cannabis-based Medicines Introduction
      • 12.5.4 Revive Therapeutics Revenue in Cannabis-based Medicines Business (2014-2019)
      • 12.5.5 Revive Therapeutics Recent Development
    • 12.6 MGC Pharmaceuticals
      • 12.6.1 MGC Pharmaceuticals Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Cannabis-based Medicines Introduction
      • 12.6.4 MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2014-2019)
      • 12.6.5 MGC Pharmaceuticals Recent Development
    • 12.7 ECHO Pharmaceuticals
      • 12.7.1 ECHO Pharmaceuticals Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Cannabis-based Medicines Introduction
      • 12.7.4 ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2014-2019)
      • 12.7.5 ECHO Pharmaceuticals Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Marijuana (medical cannabis) is used to treat nausea, pain, anxiety, MS, insomnia, epilepsy, and other conditions. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. In the medicines market, Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration.
      In 2018, the global Cannabis-based Medicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Cannabis-based Medicines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cannabis-based Medicines development in United States, Europe and China.

      The key players covered in this study
      GW Pharmaceuticals plc
      INSYS Therapeutics
      Aequus Pharmaceuticals
      Axim Biotechnologies
      Revive Therapeutics
      MGC Pharmaceuticals
      ECHO Pharmaceuticals
      ...

      Market segment by Type, the product can be split into
      CBD (Cannabidiol) Based
      THC (Tetrahydrocannabinol) Based
      Others

      Market segment by Application, split into
      Oral Solution
      Tablets
      Patches
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Cannabis-based Medicines status, future forecast, growth opportunity, key market and key players.
      To present the Cannabis-based Medicines development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Cannabis-based Medicines are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now